Rufinamide | FDA Orange Book | Approved Drug Product List | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Rufinamide
FDA Orange Book

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Rufinamide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

14 API Suppliers, 9 USDMF, 2 EU WC, 8 NDC API, 9 Listed Suppliers, $ API Reference Price

14 API Suppliers
9 USDMF
2 EU WC
8 NDC API
9 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

46 FDF Dossiers, 26 FDA Orange Book, 15 Europe, 5 Canada

46 FDF Dossiers
26 FDA Orange Book
15 Europe
5 Canada

DRUG PRODUCT COMPOSITIONS

SUSPENSION;ORAL - 40MG/ML, TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 200MG, TABLET;ORAL - 400MG

SUSPENSION;ORAL - 40MG/ML
TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 200MG
TABLET;ORAL - 400MG

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 7 SPI Pharma, 11 DKSH, 4 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 15 BASF, 10 Corel Pharma Chem, 4 DFE Pharma, 2 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 29 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 24 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

55 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 30 Thickeners and Stabilizers, 25 Controlled & Modified Release, 20 Direct Compression, 18 Film Formers & Plasticizers, 16 Granulation, 15 Topical, 14 Lubricants & Glidants, 13 Taste Masking, 12 Rheology Modifiers, 11 Solubilizers, 10 Co-Processed Excipients, 9 Disintegrants & Superdisintegrants, 8 Chewable & Orodispersible Aids, 6 Emulsifying Agents, 5 Parenteral, 5 Empty Capsules, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Coloring Agents, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

55 Fillers, Diluents & Binders
49 Coating Systems & Additives
30 Thickeners and Stabilizers
25 Controlled & Modified Release
20 Direct Compression
18 Film Formers & Plasticizers
16 Granulation
15 Topical
14 Lubricants & Glidants
13 Taste Masking
12 Rheology Modifiers
11 Solubilizers
10 Co-Processed Excipients
9 Disintegrants & Superdisintegrants
8 Chewable & Orodispersible Aids
6 Emulsifying Agents
5 Parenteral
5 Empty Capsules
4 Vegetarian Capsules
4 API Stability Enhancers
4 Coloring Agents
1 Soft Gelatin
1 Surfactant & Foaming Agents

DIGITAL CONTENT

21 News #PharmaBuzz

21 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 15 Regulatory FDF Prices, 13 Annual Reports

2 US Medicaid Prescriptions
15 Regulatory FDF Prices
13 Annual Reports

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

4 Health Canada Patents

4 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 USP, 3 Others

3 USP
3 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 1,718 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

26 All

01 1ALKEM LABS LTD

02 3AUROBINDO PHARMA

03 1BIONPHARMA

04 1CHARTWELL RX

05 4EISAI INC

06 2GLENMARK PHARMS LTD

07 3HETERO LABS LTD III

08 3HIKMA

09 4LUPIN LTD

10 2MICRO LABS

11 2NORVIUM BIOSCIENCE

filter Dosage Reset all filters

26 All

01 8SUSPENSION;ORAL

02 18TABLET;ORAL

filter Regulatory Info Reset all filters

26 All

01 1DISCN

02 25RX

filter Brand Name Reset all filters

26 All

01 4BANZEL

02 22RUFINAMIDE

filter RLD Reset all filters

26 All

01 22No

02 4Yes

List of Suppliers

Product Main Page

01

EISAI INC

Immuno-Oncology 360

Not Confirmed

EISAI INC

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

Brand Name : BANZEL

Dosage Form : TABLET;ORAL

Dosage Strength : 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 2008-11-14

Application Number : 21911

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

EISAI INC

Immuno-Oncology 360

Not Confirmed

EISAI INC

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code : AB

Brand Name : BANZEL

Dosage Form : TABLET;ORAL

Dosage Strength : 200MG

Approval Date : 2008-11-14

Application Number : 21911

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EISAI INC

Immuno-Oncology 360

Not Confirmed

EISAI INC

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code : AB

Brand Name : BANZEL

Dosage Form : TABLET;ORAL

Dosage Strength : 400MG

Approval Date : 2008-11-14

Application Number : 21911

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

EISAI INC

Immuno-Oncology 360

Not Confirmed

EISAI INC

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code : AB

Brand Name : BANZEL

Dosage Form : SUSPENSION;ORAL

Dosage Strength : 40MG/ML

Approval Date : 2011-03-03

Application Number : 201367

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

HETERO LABS LTD III

Immuno-Oncology 360

Not Confirmed

HETERO LABS LTD III

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

Brand Name : RUFINAMIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 200MG

Approval Date : 2021-05-11

Application Number : 204993

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

HIKMA

Immuno-Oncology 360

Not Confirmed

HIKMA

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

Brand Name : RUFINAMIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 200MG

Approval Date : 2016-05-16

Application Number : 204988

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

HIKMA

Immuno-Oncology 360

Not Confirmed

HIKMA

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

Brand Name : RUFINAMIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 400MG

Approval Date : 2016-05-16

Application Number : 204988

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

LUPIN LTD

Immuno-Oncology 360

Not Confirmed

LUPIN LTD

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code :

Brand Name : RUFINAMIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 100MG

Approval Date : 2022-08-17

Application Number : 204964

RX/OTC/DISCN : RX

RLD : No

TE Code :

Product Web Link

Digital Content

Corporate PDF

09

LUPIN LTD

Immuno-Oncology 360

Not Confirmed

LUPIN LTD

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

Brand Name : RUFINAMIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 200MG

Approval Date : 2022-08-17

Application Number : 204964

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Product Web Link

Digital Content

Corporate PDF

10

LUPIN LTD

Immuno-Oncology 360

Not Confirmed

LUPIN LTD

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

Brand Name : RUFINAMIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 400MG

Approval Date : 2022-08-17

Application Number : 204964

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Product Web Link

Digital Content

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!